GlassScriptPhysician profile
Randall W Fehr
NPI 1184706624
$1,170.37
in general payments reported to CMS, 2019-2025
11 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $119 · 2021: $150 · 2022: $24.60 · 2023: $28.40 · 2024: $282 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Education: $15.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.41 |
| Education | $15.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $655.93 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $137.29 | 2025 | Caplyta |
| Allergan, INC. | $73.02 | 2019-2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $72.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.51 | 2020-2024 | Spravato |
| Bausch Health US, LLC | $44.79 | 2020 | |
| Jazz Pharmaceuticals INC. | $44.64 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.31 | 2021-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $27.28 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $13.18 | 2019 | |
| Alkermes, INC. | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Fehr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.